Urban T, Bréchot J M, Capron F, Allard P, Prudent J, Lebeau B, Rochemaure J
Service de Pneumologie, Hôpital Saint-Antoine.
Rev Mal Respir. 1991;8(5):487-92.
Five cases of Wegener's granulomatosis treated with cyclophosphamide (CPM) and prednisolone are reported. Four of these patients received intermittent intravenous boluses of cyclophosphamide with the aim of improving the prognosis and renal function and at the same time to attenuate any haematological or vesical toxicity of CPM. The initial response to treatment by boluses of CPM was favourable in all cases but three patients presented with relapses, which were sometimes repeated and boluses of CPM did not enable a remission to be maintained at the time. Recourse to continuous oral therapy in place of bolus therapy proved viable for the maintenance of remission in two cases. The bladder and haematological tolerance to the bolus was satisfactory but an episode of severe neutropenia led to an adaptation of the dose of CPM. The intermittent administration above all the low cumulative dose of CPM obtained with the boluses will explain the better vesical and haematological tolerance observed depending on the capacity to maintain a prolonged remission. The indications for boluses of CPM in the treatment of Wegener's granulomatosis remain uncertain and do not seem to be totally without inconvenience.
报告了5例用环磷酰胺(CPM)和泼尼松龙治疗的韦格纳肉芽肿病患者。其中4例患者接受间歇性静脉推注环磷酰胺,目的是改善预后和肾功能,同时减轻CPM的任何血液学或膀胱毒性。所有病例对CPM推注治疗的初始反应良好,但3例患者出现复发,有时复发反复出现,CPM推注未能维持缓解。在2例病例中,采用持续口服治疗代替推注治疗被证明对维持缓解可行。对推注的膀胱和血液学耐受性令人满意,但一次严重中性粒细胞减少症发作导致调整了CPM剂量。尤其是推注获得的CPM低累积剂量的间歇性给药,将解释根据维持长期缓解的能力观察到的更好的膀胱和血液学耐受性。CPM推注在韦格纳肉芽肿病治疗中的适应证仍不确定,似乎并非完全没有不便之处。